Dr. Anirban Mahanti

Investment Researcher

India

About Dr.

Dr. Anirban Mahanti is a renowned investment researcher and expert in the field of technology stocks. He has a Ph.D. in finance and has worked with several leading investment firms. Dr. Mahanti is the founder of 7Investing, a popular online resource for investors. He is known for his in-depth research and analysis of technology stocks, and has written extensively on the topic. Dr. Mahanti is also active on Twitter and has a strong following of investors and finance enthusiasts.

Associated Podcasts

Australian Investors Podcast

Host

Connect

Recent Appearances

How to value tech stocks (ZS, OKTA & more), inflation outlook ft. 7Investing's Dr Anirban Mahanti

Australian Investors Podcast•Jun 29, 2022•52:12•host

Ouch! 6 beaten-down stocks: SHOP, XRO, ZM, TYR, OKTA & DTC

Australian Investors Podcast•Mar 11, 2022•45:22•host

Dr. Anirban Mahanti

About Dr.

Associated Podcasts

Australian Investors Podcast

Connect

Recent Appearances

How to value tech stocks (ZS, OKTA & more), inflation outlook ft. 7Investing's Dr Anirban Mahanti

Ouch! 6 beaten-down stocks: SHOP, XRO, ZM, TYR, OKTA & DTC

Key Topics

Alcidion's (ASX:ALC) Silverlink takeover & time to buy Magellan? | ft. Anirban Mahanti & Owen Rask

Is EML Payments (ASX:EML) cheap? Bapcor (BAP) & AWS vs. Cloudflare | ft. Anirban Mahanti & Owen Rask

How overvalued is Pro Medicus (PME), Peloton (PTON) falls 30% & selling (some) TSLA, ft. Claude Walker & Anirban Mahanti

Finding the next Xero & Zoom's takeover

Live: The Evergrande collapse & is 25% in one stock too much?

Results from Altium (ALU), Zoom (ZM), Pointerra, Unity (U) & more

Rapid-fire results coverage: WiseTech, Afterpay, Snowflake, Bigtincan, Nanosonics & More!

ASX results: PME, RBL, NEA, NWL, CSL & 2 stocks to watch

Meet my new co-host, inflation vs. valuation, Nuix, putting a price on Tesla & 2 ASX stories

Interview: Dr Anirban Mahanti – Investing in hypergrowth technologies